Enterprise content is an indispensable element of business success, but life sciences organizations still struggle with the complexities associated with executing a successful content lifecycle strategy. For pharmaceutical, biotech, and medtech organizations that are on the fast track to making discoveries for the greater good, failing to address content complexity can prove particularly costly in terms of compliance. And if content produced does not meet stringent regulatory requirements, it poses risks to brand, sales, health, and even people’s lives.
We were excited to sponsor a fireside chat discussion with Xtelligent Healthcare Media, part of the TechTarget group, titled ‘People, Tech, Processes: Managing Life Science Content Complexity and Regulation’ featuring guest speakers Kathleen Pierce, Principal Analyst with Forrester, and Dr. Ray Glemser, Founder of Glemser Technologies.
We peeled back the layers of why life sciences organizations are long overdue in evaluating their content strategies. Participants discussed why updating infrastructures with automation technology helps your content teams work better together. They agreed that automation is core to successful delivery of timely, relevant, localized – and compliant – content.
For decades, Dr. Ray Glemser has worked with life sciences organizations. He discussed the impact of content compliance and how automation can simplify it by, for example, modelling paper documents in a GUI and eliminating error-prone manual processes to support accurate, faster time to market with content assets.
Glemser talked about why businesses should shift away from unstructured content creation and adopt a structured approach. Structured content revolutionizes the paper submission process, making it simple to search and reuse up-to-date, accurate, and compliant content components. It streamlines content operations and review cycles and can cut local content-distribution costs in half.
The good news is that the long-term benefits of adopting a structured, reusable approach to content creation are huge. It’s a manageable learning curve for content authors as the plugin for Microsoft Word means it can continue to be the authoring standard. This allows subject matter experts to work in their familiar environment without having to worry about technology adoption complexity.
We also discussed why content hygiene is so vital to scaling operations. Pierce emphasized the importance of taking stock of content before embarking on any content-transformation initiative. Unfortunately, many life sciences and medtech organizations have complicated content ecosystems, with technical silos, large repositories of poorly managed legacy content, multiple content-creation teams with little coordination, and taxonomies that have no relationship to each other. Identifying and cleaning up problem areas in advance enables teams to set themselves up for success. Without this preparatory work, expensive investments in technology and change management are more likely to underdeliver.
Automation is an opportunity to support a cross-functional team with a universal aligned taxonomy. It optimizes the submission process and eliminates the time-consuming, error prone process.
Companies should replace manual processes with automation wherever possible to make the best use of personnel and technologies. Glemser and Pierce agreed that content automation is a worthwhile investment that can deliver long-term advantages for your people and your business. For your people, these tools reduce admin work, facilitate collaboration and knowledge sharing, streamline reviews and approvals, and track content consistency in language, format, and brand across every output channel. For your business, automation helps prevent the errors and omissions that can trigger hefty fines. Being confident that your content meets compliance requirements is crucial in the highly regulated life sciences industry.
Quark knows content and has a long history in delivering tools that help enterprises modernize their content operations infrastructure to win in their target markets. We took our 40+ years of understanding content complexity and infused it into Quark Publishing Platform NextGen. This platform automates complex content management processes so organizations in any industry can achieve their most important objectives – from digital transformation and customer satisfaction to regulatory compliance and revenue growth. Deep investments in AI enable enterprises to automate key areas of the content lifecycle journey: from accurate creation, collaboration, and assembly to delivering personalized, compliance-controlled content and measuring content consumption. Glemser’s ComplianceAuthor AI provides the life sciences industry with best-practice configurations of Quark Publishing Platform NextGen and integrations with natural language technology, generative AI capabilities and regulatory information management systems in a single-tenant, validated GxP cloud solution to help bring innovative medicines to market while complying with demanding GxP regulatory requirements.
Watch “Virtual Fireside Chat: Cutting Through Content Complexity to Create a Culture of Compliance” to learn how life sciences and med tech organizations can modernize their content strategies with content automation and see immediate benefits in operational efficiencies, cross-functional team collaboration and ability to better manage and publish regulated content for any digital output.
To learn more about Quark Publishing Platform NextGen, you can request a demo.